Declining incidence of nonbacteremic pneumococcal ppneumonia in hospitalized elderly patients at a tertiary care hospital after the introduction of pneumococcal vaccines in Taiwan, 2004 to 2008

Journal of the American Geriatrics Society

Volumn 58, Issue 1, 2010, Pages 195-196

  Lin, Sheng Hsiang ^a   Tan, Che Kim ^b   Lai, Chih Cheng ^c   Wang, Cheng Yi ^c   Hsueh, Po Ren ^d  

^a Taipei County Hospital   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c CARDINAL TIEN HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGED; CHILD; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; GERIATRIC PATIENT; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; INFECTION RATE; LETTER; MAJOR CLINICAL STUDY; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; SCHOOL CHILD; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TAIWAN; TERTIARY HEALTH CARE; VACCINATION;

AGED; HOSPITALIZATION; HUMANS; INCIDENCE; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; TAIWAN; TIME FACTORS; VACCINES, CONJUGATE;

EID: 73949085213     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2009.02658.x     Document Type: Letter

References (10)

1. Hsueh PR, Wu JJ, Hsiue TR. Invasive Streptococcus pneumoniae infection associated with rapidly fatal outcome in Taiwan. J Formos Med Assoc 1996 95 : 364 371.
2. Dominguez A, Salleras L, Fedson DS et al. Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: A case-control study. Clin Infect Dis 2005 40 : 1250 1257.
3. Spindler C, Hedlund J, Jasir A et al. Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden. Vaccine 2008 26 : 5541 5546.
4. McBean AM, Park YT, Caldwell D et al. Declining invasive pneumococcal disease in the U.S. elderly. Vaccine 2005 23 : 5641 5645.
5. Whitney CG, Farley MM, Hadler J et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003 348 : 1737 1746.
6. Lexau CA, Lynfield R, Danila R et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005 294 : 2043 2051.
7. Musher DM. Infections caused by Streptococcus pneumoniae: Clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis 1992 14 : 801 807.
8. Vila-Corcoles A, Ochoa-Gondar O, Hospital I et al. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: The EVAN-65 study. Clin Infect Dis 2006 43 : 860 868.
9. Musher DM, Rueda-Jaimes AM, Graviss EA et al. Effect of pneumococcal vaccination: A comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia. Clin Infect Dis 2006 43 : 1004 1008.
10. Vila-Corcoles A, Salsench E, Rodriguez-Blanco T et al. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: A matched case-control study. Vaccine 2009 27 : 1504 1510.